Related Experiment Video
Updated: Aug 29, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Caspase-8 Polymorphism and Colorectal Cancer Risk: A Meta-Analysis of 35,854 Subjects
1The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Objective:
Caspase-8 (CASP8) is essential for apoptotic clearance of transformed cells and is encoded by the CASP8 gene. The CASP8 -652 6N del polymorphism (rs3834129) has been studied in relation to colorectal cancer (CRC) risk with conflicting outcomes. This meta-analysis aims to provide a consolidated assessment of the association between rs3834129 and susceptibility to CRC.
Methods:
Eligible case-control studies published up to January 2025 were systematically retrieved from PubMed, Web of Science, and China National Knowledge Infrastructure. For each study, the association of the CASP8 -652 6N del polymorphism with CRC risk was assessed using odds ratios (ORs) and 95% confidence intervals (CIs).
Results:
A total of 22 studies derived from 12 eligible articles involving 15,327 patients with CRC and 20,527 control subjects were enrolled in this meta-analysis. Collectively, the CASP8 -652 6N del variant correlated with reduced CRC risk under the heterozygote genetic model (OR=0.94, 95% CI: 0.89-0.99). When stratifying analyses according to ethnic background, comparable protective associations were detected within Asian populations. By contrast, no statistically meaningful link was identified between this polymorphism and CRC susceptibility among Caucasian individuals. Further stratification based on tumor site revealed no significant correlations for either colon cancer or rectal cancer subgroups.
Conclusions:
This meta-analysis provides evidence that the CASP8 -652 6N del polymorphism may be linked to a moderately decreased risk of CRC in Asian subjects.
